PCOS Has a New Name and It Actually Matters

If you’ve been living with polycystic ovary syndrome, or if you’ve ever been told you “might have PCOS” based on an ultrasound, you may have already heard the news: PCOS has officially been renamed. As of May 2026, the condition is now called polyendocrine metabolic ovarian syndrome, or PMOS.

A one-letter change. A decades-long fight to get there. And a shift that is far more significant than it might appear on the surface.

Here’s what you need to know and why it matters for the care you deserve.

Why the Name Changed

The name polycystic ovary syndrome has been in use since the 1930s. It was based on the observation that some women with the condition had an unusual number of follicles visible on ultrasound, what were mistakenly described as cysts.

The problem is that those aren’t cysts. They never were. They are immature follicles that fail to ovulate due to hormonal disruption, not growths, not pathological cysts, and not primarily an ovarian problem. The name “polycystic ovary syndrome” implied that this was, at its core, a structural condition of the ovaries. That framing led to decades of fragmented care, delayed diagnoses, and patients being dismissed or undertreated because their ovaries looked “fine” on imaging.

In reality, PCOS/PMOS is a complex, multisystem condition involving the endocrine system, metabolic function, reproductive health, and beyond. The renaming to polyendocrine metabolic ovarian syndrome finally reflects that.

The change was published in The Lancet on May 12, 2026, following an 11-year global consensus process that gathered input from over 22,000 patients, clinicians, and researchers across the world.

What PMOS Actually Is

PMOS affects roughly 1 in 8 women. Despite being one of the most common hormonal conditions of reproductive age, it remains dramatically underdiagnosed.

The defining features are not cysts. They are:

- Hormonal disruption: typically elevated androgens (like testosterone), which can cause irregular or absent periods, acne, and excess hair growth

- Metabolic dysfunction: most commonly insulin resistance, which affects how the body processes glucose and regulates weight

- Reproductive effects: irregular ovulation, which impacts fertility

- Systemic downstream effects: including increased risk of type 2 diabetes, cardiovascular disease, endometrial issues, and mental health conditions like anxiety and depression

The new name leads with what is actually happening: a polyendocrine (meaning it involves multiple hormonal systems) and metabolic condition that happens to involve the ovaries, not a disease of ovarian cysts.

Why This Name Change Is a Big Deal for Patients

Language shapes how a condition is understood, researched, funded, and treated. “Polycystic ovary syndrome” sent the wrong message to everyone in the room, patients, clinicians, insurers, and researchers alike.

It sent patients to gynecologists for a condition that also needed endocrinologists and metabolic specialists. It led to care that focused almost entirely on fertility and reproduction, while ignoring the long-term metabolic risks that follow these women for their entire lives. It left patients confused about their diagnosis, especially those who were told they had PCOS but didn’t see cysts on their imaging.

PMOS is a more accurate name. It signals that this is a systemic, lifelong condition, one that requires coordinated, multidisciplinary care. That has implications for how physicians are trained to recognize and treat it, how research funding is allocated, and how patients understand their own bodies.

What This Means for Your Pelvic Floor

Whether you’re newly diagnosed, have been managing this condition for years, or are just recognizing yourself in this description for the first time I want you to understand that PMOS doesn’t live only in your labs or your ultrasound. It lives in your body, in how you move, how you feel, and how your pelvic floor functions.

Insulin resistance and elevated androgens affect tissue quality, inflammation, and pain sensitivity throughout the pelvis. Irregular cycles and hormonal shifts affect pelvic floor tone, bowel and bladder function, and pain with sex. And for many women, the physical symptoms of PMOS, pelvic pressure, pain, bloating, heaviness, are dismissed as “just part of having PCOS,” when in reality, there is a musculoskeletal component that can be directly addressed.

Pelvic floor physical therapy is not a cure for PMOS, and I work collaboratively with OBGYNs, endocrinologists, and other providers who are managing the hormonal and metabolic side of this condition. But the pelvic floor is part of this picture. And when it hasn’t been addressed, it often explains why someone is still experiencing symptoms despite doing everything else right.

You’ve Always Deserved a Complete Explanation

If you’ve ever walked out of an appointment more confused than when you walked in, if you’ve been handed a diagnosis and sent home without a real plan, if you’ve spent years managing symptoms that feel disconnected from each other, you are not alone, and you are not wrong to want more.

PMOS is a complex, whole-body condition. Your care should be too.

Ready to take the first step? Book your free consultation at <https://app.pteverywhere.com/woven/bookingonline>. Woven Pelvic Health and Wellness is located in Denver, CO and serves women throughout the Denver metro area.

Dr. Ashley Castellanos, PT, DPT is the owner and founder of Woven Pelvic Health and Wellness in Denver, Colorado. She specializes in pelvic floor physical therapy for women across all stages of life, with advanced training in manual therapy, dry needling, orthopedics, and trauma-informed care.